• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Cancer Research
  2. Vol 7 (4), 2011
  3. 278-288
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Cancer Research

Year: 2011 | Volume: 7 | Issue: 4 | Page No.: 278-288
DOI: 10.3923/ijcr.2011.278.288

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 390

Search


Authors


Sabry A. EL-Naggar

Country: Egypt

Ahmed A. El-Barbary

Country: Egypt

Merveet A. Mansour

Country: Egypt

Fawzya Abdel-Shafy

Country: Egypt

Shaimaa Talat

Country: Egypt

Keywords


  • Synthetic
  • organic compounds
  • 1
  • 3
  • 4-thiadiazoles
  • 1
  • 2
  • 4-triazines
  • anti-tumor
  • efficacy
  • EAC-model
Research Article

Anti-tumor Activity of Some 1,3,4-thiadiazoles and 1,2,4-triazine Derivatives against Ehrlichs Ascites Carcinoma

Sabry A. EL-Naggar, Ahmed A. El-Barbary, Merveet A. Mansour, Fawzya Abdel-Shafy and Shaimaa Talat
Recently, identifying new chemo-preventive agents to replace the current chemotherapies consider one of the most important approaches which could be crucial for cancer treatment. The present study was conducted to evaluate the anti-tumor activity of some newly synthesized heterocyclic 1,3,4-thiadiazole and 1,2,4-triazine derivatives. Different groups of mice were inoculated with Ehrlichs Ascites Carcinoma cells (EAC) intra-peritoneal (i.p.) (2x106 cells mouse-1). After one day of inculcation, mice were treated either with cisplatin (reference drug) or with twenty five different new derivatives of 1,3,4-thiadiazoles or 1,2,4-triazines. The anti-tumor activity of these derivatives against EAC-bearing mice were monitored through the changes in the total body weight, total ascetic volume, the number of live and dead tumor cells, median survival time (MST) and some biochemical parameters. The results showed that only five compounds of 1,3,4-thiadiazoles significantly inhibited the tumor progression after 14 days of the treatment. Interestingly, two of these compounds increased the life span of the tumored mice by 34 and 40% when compared with the untreated group. In contrast, all 1,2,4-triazine derivatives didn’t show any potential anti-tumor activity against EAC-model. In conclusion, screening of 1,3,4-thiadiazole derivatives showed a potential activity against EAC while, 1,2,4-triazine derivatives didn’t show any marked anti-tumor activity.
PDF Fulltext XML References Citation

How to cite this article

Sabry A. EL-Naggar, Ahmed A. El-Barbary, Merveet A. Mansour, Fawzya Abdel-Shafy and Shaimaa Talat, 2011. Anti-tumor Activity of Some 1,3,4-thiadiazoles and 1,2,4-triazine Derivatives against Ehrlichs Ascites Carcinoma. International Journal of Cancer Research, 7: 278-288.

DOI: 10.3923/ijcr.2011.278.288

URL: https://scialert.net/abstract/?doi=ijcr.2011.278.288

Related Articles

Experimental Approach to Treatment of Colorectal Cancer by Herbs and Their Constituents: An Overview on in vivo and in vitro Protocols and Molecular Targets
Numerical Simulation of Tumor Development Stages Using Artificial Neural Network
Anti-cancerous Plants of Uttarakhand Himalaya: A Review
Chemopreventive Effect of Oil, Extracted from Coriandrum sativum on Mice Bearing Solid Ehrlich Tumor
Antitumor Efficacy of Salenostemma Argel and/or γ-Irradiation Against Ehrlich Carcinoma
Antitumour Activity of cis-bis{imidazo(1,2-α)- pyridineplatinum (II)
Potential Anticancer Natural Product Against Human Lung Cancer Cells

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved